Development of Biomarkers to Optimize Pediatric Patient Management: What Makes Children Different?

Authors:

Abstract
Despite the frequent utilization of biomarkers in medical practice, there is a relative paucity of information regarding validated pediatric biomarkers. Frequently, biomarkers found to be efficacious in adults are extrapolated to the pediatric clinical setting without considering that the pathogenesis of many diseases is distinctly different in children, and ontogeny directly influences disease evolution and therapeutic response in children. New and innovative approaches are necessary to provide reliable, validated biomarkers that can be used to improve and advance pediatric medical care.
Funding Information
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32 HD069038)

This publication has 85 references indexed in Scilit: